openPR Logo
Press release

Ursodeoxycholic Acid Market to Reach US$ 1120.55 million by 2031 | Glenmark Pharmaceuticals Inc., Biobrick Pharma, Casca Remedies Pvt. Ltd.

10-14-2024 01:12 PM CET | Chemicals & Materials

Press release from: DataM Intelligence 4market Research LLP

Ursodeoxycholic Acid Market

Ursodeoxycholic Acid Market

DataM Intelligence has released a new research report on the Ursodeoxycholic Acid market. The report provides a detailed analysis of current and emerging trends, offering insights into the market dynamics. It utilizes Porter's Five Forces model to assess key factors such as supplier and customer relationships, risks from various agents, competitive intensity, and opportunities for new entrants. The study also includes research data from various companies, analyzing factors like benefits, gross margins, and strategic decisions in the global market. The report is enriched with tables, charts, and infographics for a clear presentation of the findings.

The Global Ursodeoxycholic Acid Market reached US$ 581.17 million in 2023 and is expected to reach US$ 1120.55 million by 2031 growing with a CAGR of 9.8% during the forecast period 2024-2031.

Get a Free Sample Research PDF - https://datamintelligence.com/download-sample/ursodeoxycholic-acid-market

Ursodeoxycholic Acid (UDCA) is a bile acid that is naturally produced in the body and plays a significant role in the digestion and absorption of fats. It is primarily used in medical settings for its therapeutic effects in treating liver diseases, particularly in patients with cholestatic liver disorders such as primary biliary cholangitis (PBC) and certain types of gallstones. UDCA works by reducing the cholesterol content in bile, promoting the dissolution of cholesterol gallstones, and improving liver function by enhancing bile flow and protecting liver cells from damage. It has also shown potential benefits in conditions like non-alcoholic fatty liver disease (NAFLD) and liver cirrhosis.

List of the Key Players in the Ursodeoxycholic Acid Market:

Glenmark Pharmaceuticals Inc., Biobrick Pharma, Casca Remedies Pvt. Ltd., Wellona Pharma, ADDII BIOTECH PRIVATE LIMITED., Curivo Healthcare, Zoic Life Sciences, Biofield Pharma Pvt Ltd, Jabs Biotech Pvt. Ltd, and Captee.

Key Developments:

In August 2024, Gilead Sciences, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Livdelzi (seladelpar) for the treatment of primary biliary cholangitis (PBC). This approval allows Livdelzi to be used in combination with ursodeoxycholic acid (UDCA) for adults who have not responded adequately to UDCA. Additionally, it can be prescribed as a monotherapy for patients who are unable to tolerate UDCA.

Research Process:

Both primary and secondary data sources have been used in the global Ursodeoxycholic Acid Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Segment Covered in the Ursodeoxycholic Acid Market:

By Type: Synthetic Ursodeoxycholic Acid (UDCA), Biological Ursodeoxycholic Acid (UDCA)

By Application: Gallstones, Primary Biliary Cholangitis (PBC), Primary Sclerosing Cholangitis (PSC), Non-Alcoholic Fatty Liver Disease (NAFLD), Other Liver and Biliary Diseases

By Form: Tablets, Capsules, Suspension

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/ursodeoxycholic-acid-market

Regional Analysis:

➣ North America (US, Canada, Mexico)

➣ Europe (Germany, Russia, UK, France, Italy, Spain, Rest of Europe)

➣ Asia-Pacific (China, India, Japan, Australia, Rest of Asia Pacific)

➣ South America (Brazil, Argentina, Rest of South America)

➣ Middle East and Africa

**The full version of the report includes an in-depth analysis of emerging players and startups, which will provide valuable insights into the evolving market landscape and key strategies being adopted**

Chapter Outline:

⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Ursodeoxycholic Acid market segments, study objectives, and years considered.

⏩ Market Landscape: The competition in the Global Ursodeoxycholic Acid Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.

⏩ Companies Profiles: The global Ursodeoxycholic Acid market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.

⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.

⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Ursodeoxycholic Acid Market.

⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

⏩ Research Findings: This section of the report showcases the findings and analysis of the report.

⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.

Have any Query? Talk to our Expert @ https://www.datamintelligence.com/enquiry/ursodeoxycholic-acid-market

The Research Report Offers Answers To The Following Questions:

☛ What is the expected growth rate of the global market for the forecast period?

☛ What are the key driving factors that are responsible to shape the fate of the Ursodeoxycholic Acid market during the forecast period?

☛ What will be the overall size of the market during the analysis period?

☛ What are the prominent market trends which influence the development of the Ursodeoxycholic Acid market across various regions?

☛ Who are the key market players and the market strategies that have helped them to secure the leading position in the global market?

☛ What are the challenges and threats that are likely to act as a barrier to the growth of the Ursodeoxycholic Acid market?

☛ What are the major opportunities that the companies can get to attain success in the world?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Ursodeoxycholic Acid Market to Reach US$ 1120.55 million by 2031 | Glenmark Pharmaceuticals Inc., Biobrick Pharma, Casca Remedies Pvt. Ltd. here

News-ID: 3691096 • Views:

More Releases from DataM Intelligence 4market Research LLP

United States Carbon Fiber Tapes Market 2024-2031: Comprehensive Analysis of Prepreg and Dry Tapes, Resin Types, Manufacturing Processes, and Industrial Applications Across Aerospace, Automotive, and Renewable Energy Sectors
United States Carbon Fiber Tapes Market 2024-2031: Comprehensive Analysis of Pre …
Global Carbon Fiber Tapes Market reached US$ 2.7 billion in 2023 and is expected to reach US$ 6.9 billion by 2031, growing with a CAGR of 12.5% during the forecast period 2024-2031. The carbon fiber tapes market focuses on lightweight, high-strength materials made from continuous carbon fibers pre-impregnated or dry-woven into tapes. These tapes are widely used in aerospace, automotive, sports, and wind energy industries for reinforcement and weight reduction. Their
United States Exocrine Pancreatic Insufficiency Treatment Market 2024-2031: Comprehensive Analysis of Pancreatic Enzyme Replacement Therapy, Nutritional Management, Emerging Therapies, and Strategic Growth Opportunities
United States Exocrine Pancreatic Insufficiency Treatment Market 2024-2031: Comp …
The Global Exocrine Pancreatic Insufficiency Treatment Market reached US$ 3.30 billion in 2023 and is expected to reach US$ 5.37 billion by 2031, growing at a CAGR of 6.4% during the forecast period 2024-2031. Exocrine Pancreatic Insufficiency (EPI) is a condition where the pancreas fails to produce sufficient digestive enzymes, leading to malabsorption, nutrient deficiencies, and gastrointestinal issues. Treatments primarily involve pancreatic enzyme replacement therapy (PERT), dietary modifications, and adjunctive nutritional
Herpes Labialis Drugs Market 2024-2031: Comprehensive Analysis of Antiviral Therapeutics, Topical and Oral Formulations, Emerging Therapies, and Strategic Market Opportunities | GlaxoSmithKline Pharmaceuticals, Bauch Health Inc., Novartis AG
Herpes Labialis Drugs Market 2024-2031: Comprehensive Analysis of Antiviral Ther …
The global herpes labialis drugs market reached US$ 1.16 billion in 2023 and is expected to reach US$ 1.7 billion by 2031 growing with a CAGR of 4.8% during the forecast period 2024-2031. Herpes labialis, commonly known as cold sores, is caused by the Herpes Simplex Virus-1 (HSV-1). Treatment options include antiviral drugs such as acyclovir, valacyclovir, famciclovir, and topical formulations, which help reduce symptoms, accelerate healing, and prevent recurrence. The
United States Chronic Inflammatory Demyelinating Polyneuropathy Market 2024-2031: In-Depth Analysis of Immunoglobulin Therapy, Corticosteroids, Plasma Exchange, and Emerging Biologics | Top Companies are Grifols, Baxter, Kedrion S.p.A
United States Chronic Inflammatory Demyelinating Polyneuropathy Market 2024-2031 …
Chronic Inflammatory Demyelinating Polyneuropathy Market is valued at a significant CAGR during the forecast period (2024-2031). Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) is a rare autoimmune disorder that leads to progressive weakness, numbness, and sensory impairment in the limbs. Current treatments include corticosteroids, intravenous immunoglobulin (IVIg), plasma exchange (plasmapheresis), and emerging biologics. The market is expanding due to increasing disease awareness, advances in therapeutic options, early diagnosis, and growing adoption of patient-centric

All 5 Releases


More Releases for Ursodeoxycholic

Oral Ursodeoxycholic Acid Market New Product Development & Latest Trends
The global oral ursodeoxycholic acid market is valued at approximately $850 million in 2024. Forecasts indicate a robust growth trajectory, anticipating a market value of around $1.5 billion by 2034. This growth reflects a Compound Annual Growth Rate (CAGR) of 6.4% from 2025 to 2034. Exactitude Consultancy., Ltd. released a research report offers a comprehensive examination of the various processes and materials used in the production of Oral Ursodeoxycholic Acid market
Ursodeoxycholic Acid Market to see Booming Business Sentiments
The latest study released on the Global Ursodeoxycholic Acid Market by USD Analytics Research evaluates market size, trend, and forecast to 2030. The Ursodeoxycholic Acid market study covers significant research data and proofs to be a handy resource document for managers, analysts, industry experts and other key people to have ready-to-access and self-analyzed study to help understand market trends, growth drivers, opportunities and upcoming challenges and about the competitors. Key Players
Ursodeoxycholic Acid API Market Size, Share, Development by 2025
LP INFORMATION recently released a research report on the Ursodeoxycholic Acid API analysis, which studies the Electrical Cord Reels's industry coverage, current market competitive status, and market outlook and forecast by 2025. Global “Ursodeoxycholic Acid API 2020-2025” Research Report categorizes the global Ursodeoxycholic Acid API by key players, product type, applications and regions,etc. The report also covers the latest industry data, key players analysis, market share,
Ursodeoxycholic Acid Market Trends and Dynamic 2025 | Arcelor Chemicals
Global Ursodeoxycholic Acid Market: Overview Ursodeoxycholic acid (UDCA) is essentially bile acid ingested in the liquid form or in the form of a tablet to cure gallstones. Those can cure or thwart the progress of cystic fibrosis-related liver disorder. UDCA transforms the bile acid pool by lowering the levels of hydrophobic bile acids. This increases the amount of nontoxic hydrophilic bile acids. Besides, UDCA can slow down the development of gastroesophageal
Global Ursodeoxycholic Acid Industry Market Analysis & Forecast 2018-2023
Global Ursodeoxycholic Acid Industry has been utilized in the administration of puppies with incessant hepatitis and felines with lymphocytic plasmacytic cholangitis. It is accepted to be most useful in scatters where bile poisonous quality assumes an imperative job in the continuous pathology. The adequacy of Global Ursodeoxycholic Acid Industry in veterinary patients has not been certainly settled, in spite of the fact that reports recommend it might have some advantage
Ursodeoxycholic Acid Market- ICE, Grindeks, Mitsubishi, Daewoong chemical, Pharm …
Ursodeoxycholic Acid is also known as ursodiol (USAN). Ursodeoxycholic acid (3a, 7ß-2-hydroxy-5ß-bile acid, UDCA) was first found in the bile of a black bear. Ursodeoxycholic Acid is an important clinical drug in the treatment of gallstones, cholecystitis, PBC, and PSC and has broad market prospects. In previous work, ursodeoxycholic acid was prepared by traditional organic synthesis. In this report, the Ursodeoxycholic Acid we mentioned is Ursodeoxycholic Acid API. And the CAS number